Saturday - April 18, 2026

Category Archives: Science

Catheter-Related Bloodstream Infections Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s “Catheter-Related Bloodstream Infections Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Catheter-Related Bloodstream Infections pipeline landscape. It covers the Catheter-Related Bloodstream Infections Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Tetanus Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Tetanus Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Tetanus pipeline landscape. It covers the Tetanus Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Tetanus Pipeline … Continue reading →

Codex Labs Showcases Integrative Skin-Gut-Brain Solutions at 2026 CNDA Conference

LONG BEACH, Calif. – April 13, 2026 – Codex Labs, a biotech skincare company focused on integrative dermatology and microbiome-friendly skin-gut solutions, is honored to participate in the California Naturopathic Doctors Association’s (CNDA) annual conference. The world’s top Naturopathic Doctors … Continue reading →

Graves’ Disease Treatment Market Size in the 7MM was ~ USD 4,400 million in 2023 and It is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Graves’ Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the … Continue reading →

Head and Neck Cancer Clinical Trial Pipeline Expands as 80+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Head and Neck Cancer Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Head and Neck Cancer pipeline landscape. It covers the Head and Neck Cancer Pipeline drug profiles, including clinical and … Continue reading →

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s, “Metastatic Castration-Resistant Prostate Cancer Pipeline Insights 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer pipeline landscape. It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including clinical and … Continue reading →

Vascular Dementia Clinical Trial Pipeline Accelerates as 11+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Vascular Dementia Pipeline Insights 2026” report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Vascular Dementia pipeline landscape. It covers the Vascular Dementia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Acute On Chronic Liver Failure Clinical Trial Pipeline Gains Momentum: 3+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Acute On Chronic Liver Failure Pipeline Insight 2026” report provides comprehensive insights about 3+ companies and 5+ pipeline drugs in the Acute On Chronic Liver Failure pipeline landscape. It covers the Acute On Chronic Liver Failure pipeline drug profiles, … Continue reading →